Andon Health Co., Ltd. - Laporan Laba Rugi (TTM)

Andon Health Co., Ltd.
CN ˙ SZSE
CN¥ 38.63 ↑0.39 (1.02%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Andon Health Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2022
01-01
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,801 2,008 2,029 1,537 1,191 2,397 23,812 25,095 26,196 26,315 6,074 5,332 4,471 3,231 2,498 2,299 2,578 2,592 2,337 2,007
Change (%) 11.49 1.04 -24.27 -22.48 101.20 893.36 5.39 4.39 0.46 -76.92 -12.22 -16.14 -27.73 -22.69 -7.95 12.13 0.55 -9.85 -14.14
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 837 907 940 832 729 885 4,686 4,915 5,055 5,529 2,021 2,008 1,769 1,275 1,000 815 962 785 718 645
Change (%) 8.29 3.72 -11.54 -12.33 21.34 429.55 4.89 2.86 9.38 -63.45 -0.66 -11.86 -27.94 -21.55 -18.56 18.09 -18.41 -8.50 -10.26
% of Revenue 46.48 45.14 46.34 54.13 61.21 36.91 19.68 19.58 19.30 21.01 33.27 37.66 39.58 39.46 40.04 35.43 37.31 30.28 30.74 32.12
Gross Operating Profit 964 1,102 1,089 705 462 1,512 19,126 20,180 21,141 20,786 4,053 3,324 2,702 1,956 1,498 1,485 1,616 1,807 1,619 1,362
Change (%) 14.28 -1.17 -35.25 -34.44 227.20 1,164.73 5.51 4.76 -1.68 -80.50 -17.99 -18.72 -27.59 -23.43 -0.87 8.85 11.83 -10.44 -15.86
% of Revenue 53.52 54.86 53.66 45.87 38.79 63.09 80.32 80.42 80.70 78.99 66.73 62.34 60.42 60.54 59.96 64.57 62.69 69.72 69.26 67.88
SG&A 487 602 623 550 446 520 1,382 1,384 1,573 2,017 1,368 1,460 1,420 883 780 797 816 866 908 975
Change (%) 23.69 3.48 -11.71 -18.96 16.58 165.79 0.12 13.68 28.21 -32.15 6.69 -2.73 -37.80 -11.68 2.14 2.39 6.14 4.86 7.37
% of Revenue 27.04 29.99 30.72 35.81 37.44 21.69 5.80 5.51 6.00 7.66 22.53 27.38 31.76 27.34 31.23 34.66 31.65 33.41 38.86 48.59
R&D 122 77 89 75 77 67 87 112 138 265 277 308 307 278 259 254 248 261 295 308
Change (%) -37.39 16.75 -15.57 2.01 -13.30 30.87 28.25 23.27 91.87 4.64 11.23 -0.38 -9.34 -6.82 -2.24 -2.14 5.02 13.18 4.41
% of Revenue 6.79 3.81 4.40 4.91 6.46 2.78 0.37 0.45 0.53 1.01 4.56 5.78 6.87 8.62 10.39 11.03 9.63 10.06 12.63 15.35
OpEx 1,453 1,593 1,655 1,458 1,256 1,478 6,169 6,426 6,783 7,815 3,689 3,812 3,532 2,478 2,057 1,867 2,027 1,915 1,926 1,933
Change (%) 9.66 3.91 -11.92 -13.85 17.67 317.48 4.16 5.55 15.22 -52.80 3.32 -7.33 -29.83 -17.00 -9.26 8.61 -5.54 0.57 0.35
% of Revenue 80.64 79.31 81.56 94.85 105.41 61.65 25.91 25.61 25.89 29.70 60.74 71.49 79.00 76.71 82.35 81.18 78.64 73.88 82.42 96.32
Operating Income 349 415 374 79 -64 919 17,642 18,668 19,413 18,500 2,385 1,520 939 753 441 433 551 677 411 74
Change (%) 19.15 -9.95 -78.86 -181.53 -1,525.44 1,819.08 5.82 3.99 -4.70 -87.11 -36.26 -38.22 -19.84 -41.41 -1.88 27.29 22.94 -39.32 -82.04
% of Revenue 19.36 20.69 18.44 5.15 -5.41 38.35 74.09 74.39 74.11 70.30 39.26 28.51 21.00 23.29 17.65 18.82 21.36 26.12 17.58 3.68
Interest Expense -4 -7 -17 -11 -13 -13 -14 -7 -7 -5 -2 -7 -15 -12 -22 -41 -46 -67 -75 -91
Change (%) 58.76 142.85 -35.10 18.36 2.55 5.72 -49.79 -2.60 -30.86 -52.28 186.96 124.57 -14.97 76.00 86.93 12.76 45.65 11.69 21.00
% of Revenue -0.24 -0.35 -0.83 -0.71 -1.09 -0.55 -0.06 -0.03 -0.03 -0.02 -0.04 -0.12 -0.33 -0.38 -0.88 -1.78 -1.79 -2.59 -3.21 -4.52
Net Income 509 242 234 39 -71 909 15,182 16,097 16,909 16,030 2,320 1,572 877 1,252 898 1,068 1,724 1,669 1,688 1,987
Change (%) -52.40 -3.27 -83.15 -278.77 -1,387.14 1,570.90 6.03 5.04 -5.20 -85.53 -32.22 -44.25 42.78 -28.29 18.94 61.45 -3.18 1.13 17.75
% of Revenue 28.26 12.07 11.55 2.57 -5.93 37.91 63.76 64.15 64.55 60.92 38.19 29.49 19.61 38.74 35.93 46.43 66.85 64.38 72.21 99.03

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista